featured
The Role of Immune Therapy in Glioblastoma: Implications of New Data
Interview by
Interview with
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Mehta MP, Gondi V, Brown PD. METIS: A phase 3 study of radiosurgery with TTFields for 1-10 brain metastases from NSCLC. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, IL. Abstract TPS9106.
- Vergote I, von Moos R, Manso L, Sessa C. Universitaire Zie INNOVATE: A phase II study of TTFields (200 kHz) concomitant with weekly paclitaxel for recurrent ovarian cancer—Updated safety and efficacy results. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, IL. Abstract 5580.
- Benavides M, Guillen C, Rivera F, et al. PANOVA: A phase II study of TTFields (150 kHz) concomitant with standard chemotherapy for front-line therapy of advanced pancreatic adenocarcinoma—Updated efficacy results. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, IL. Abstract e15790.
Disclosure statements are available on the authors' profiles:
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.